BRIDGE LINE VENTURES — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Neurvana MedicalOct 2016SEC filingmedium confidence
BiotechTustin, US
David Ferrera(Director)Robert Abrams(Director)Kenneth Baker(Director)Jeffrey Goldberg(Director)Thomas G. Fogarty(Executive Officer, Director)
Board seatRobert Abrams· per SEC Form D · $5.5M raise · filed Oct 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.